MAZE

MAZE THERAPEUTICS INC

MAZE·578784100·US·Common Stock·Healthcare - Biotechnology-13D/G

MAZE (MAZE THERAPEUTICS INC) is held by 99 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($104.5M), VANGUARD CAPITAL MANAGEMENT LLC ($53.1M), Alphabet Inc. ($41.4M). Net institutional sentiment: Mixed.

99
Holders
(5 Elite)
$649.7M
Total Value
66% (106)
Consensus
70 buying - 36 selling
13F: Insider & Congress: Updated regularly
MAZE

Smart Money Verdict

View all
Loading verdict
Held by 99 funds
5 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 14, 2026 · Activists Aug 14, 2026 · Congress none

ActivistPBParadigm BioCapital Advisors LP0.0%Aug 14, 2026
InsiderBHBernstein HaroldSell $446KAug 13, 2026
InsiderBHBernstein HaroldExercise 16K shAug 13, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.5M(+36.3%)$104.5M0.0%-0.32%
39
Increased
1.8M(+23.9%)$53.1M0.0%-28.58%
36
Unchanged
1.4M$41.4M0.0%+159.02%
0
Increased
1.1M(+197.0%)$33.1M0.2%-14.68%
56
Increased
1.1M(+22.3%)$31.5M0.0%+32.78%
35
Increased
997,533(+56.7%)$29.8M0.0%+1.59%
41
Increased
954,886(+50.1%)$28.5M0.2%+1.53%
48
Increased
964,011(+1549.4%)$28M0.0%-2.43%
46
Increased
914,572(+194.4%)$27.3M0.0%+3.53%
46
Increased
858,054(+43.0%)$25.6M0.0%+16.30%
39
Increased
852,676(+9.9%)$25.4M0.0%-27.35%
32
Increased
736,216(+13.2%)$22M0.1%+101.37%
32
Increased
393,107(+101.0%)$11.7M0.0%-20.00%
45
Increased
383,773(+69.6%)$11.5M0.0%-22.75%
41
Unchanged
366,028$10.9M1.3%+159.02%
0
Increased
321,227(+64.7%)$9.6M0.0%-21.38%
40
Increased
294,742(+39.4%)$8.8M0.0%+19.16%
36
Increased
293,144(+4.8%)$8.7M0.0%-29.42%
29
Decreased
273,932(-1.5%)$8.2M0.0%-33.05%
0
Increased
270,000(+3212.9%)$8.1M0.0%-2.29%
44

Showing 1-20 of 110

1 / 6
MAZEMAZEMAZE THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used